Nezam H. Afdhal
Beth Israel Deaconess Medical Center
and Harvard Medical School
Boston
MA 02215
USA
Name/email consistency: high
- Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? Afdhal, N.H. JAMA (2012)
- Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. Afdhal, N.H., Giannini, E.G., Tayyab, G., Mohsin, A., Lee, J.W., Andriulli, A., Jeffers, L., McHutchison, J., Chen, P.J., Han, K.H., Campbell, F., Hyde, D., Brainsky, A., Theodore, D. N. Engl. J. Med. (2012)
- Thrombocytopenia associated with chronic liver disease. Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B., Esteban, R. J. Hepatol. (2008)
- Diagnosis of liver fibrosis in 2008 and beyond. Afdhal, N.H., Manning, D. Gastroenterol. Clin. Biol. (2008)
- Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection. Afdhal, N.H., McHutchison, J.G. Aliment. Pharmacol. Ther. (2007)
- Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches. Afdhal, N.H., Esteban, R. Aliment. Pharmacol. Ther. (2007)
- Can serum markers be used to reliably detect liver fibrosis?. Afdhal, N. Nature Clinical Practice. Gastroenterology & Hepatology (2005)
- Role of epoetin alfa in maintaining ribavirin dose. Afdhal, N.H. Gastroenterol. Clin. North Am. (2004)









